Online citations, reference lists, and bibliographies.
← Back to Search

Active Human Immunodeficiency Virus Protease Is Required For Viral Infectivity.

N. Kohl, E. Emini, W. Schleif, L. Davis, J. C. Heimbach, R. Dixon, E. Scolnick, I. Sigal
Published 1988 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Retroviral proteins are synthesized as polyprotein precursors that undergo proteolytic cleavages to yield the mature viral proteins. The role of the human immunodeficiency virus (HIV) protease in the viral replication cycle was examined by use of a site-directed mutation in the protease gene. The HIV protease gene product was expressed in Escherichia coli and observed to cleave HIV gag p55 to gag p24 and gag p17 in vitro. Substitution of aspartic acid residue 25 (Asp-25) of this protein with an asparagine residue did not affect the expression of the protein, but it eliminated detectable in vitro proteolytic activity against HIV gag p55. A mutant HIV provirus was constructed that contained the Asn-25 mutation within the protease gene. SW480 human colon carcinoma cells transfected with the Asn-25 mutant proviral DNA produced virions that contained gag p55 but not gag p24, whereas virions from cells transfected with the wild-type DNA contained both gag p55 and gag p24. The mutant virions were not able to infect MT-4 lymphoid cells. In contrast, these cells were highly sensitive to infection by the wild-type virions. These results demonstrate that the HIV protease is an essential viral enzyme and, consequently, an attractive target for anti-HIV drugs.
This paper references



This paper is referenced by
10.7324/JAPS.2021.110405
Biodegradable polymeric nanocarriers for oral delivery of antiretroviral drug: Pharmacokinetic and in vitro permeability studies
S. Sunitha (2021)
10.3390/ijms22116070
Off-Target-Based Design of Selective HIV-1 PROTEASE Inhibitors
Gabriele La Monica (2021)
10.3389/fmolb.2021.659687
Molecular Mechanics Study of Flow and Surface Influence in Ligand–Protein Association
Shivansh Kaushik (2021)
10.1371/journal.pcbi.1008551
DEER-PREdict: Software for efficient calculation of spin-labeling EPR and NMR data from conformational ensembles.
G. Tesei (2021)
10.1097/QAD.0000000000002886
Fixed-dose darunavir/cobicistat in pregnancy of HIV-infected women, pharmacokinetic concerns.
P. Dash (2021)
10.1002/0471266949.BMC260
Enzymes as Drug Targets
T. Meek (2021)
10.1128/JVI.00615-21
Structural Determinants of Virion Assembly and Release in the C Terminus of the Mason-Pfizer Monkey Virus Capsid Protein
Marlene V Buckmaster (2021)
10.3390/biomedicines9030313
Management of Antiretroviral Therapy with Boosted Protease Inhibitors—Darunavir/Ritonavir or Darunavir/Cobicistat
Ruxandra Marin (2021)
10.1021/acs.jmedchem.0c00960
Sulfoximines as Rising Stars in Modern Drug Discovery? Current Status and Perspective on an Emerging Functional Group in Medicinal Chemistry.
P. Mäder (2020)
10.18488/JOURNAL.65.2020.71.1.11
Effects of Osmotic Dehydrated and Ultrasound Pre-Treated Orange Peel on Dye Removal
J. Poon (2020)
Berrikuspen historikoa ( HIV treatment . A historical overview )
Víctor Torre (2020)
10.1080/17435390.2020.1842537
Interaction of nanoparticles with biological macromolecules: a review of molecular docking studies
Abdallah S Abdelsattar (2020)
10.4155/fmc-2019-0331
Synthesis and evaluation of potent human immunodeficiency virus 1 protease inhibitors with epimeric isopropanol as novel P1' ligands.
Mei Zhu (2020)
10.1021/acs.langmuir.0c02151
Multiple Molecular Dynamics Simulations of the Inhibitor GRL-02031 Complex with Wild Type and Mutant HIV-1 Protease Reveal the Binding and Drug-Resistance Mechanism.
Ruige Wang (2020)
10.1002/slct.202000990
A Molecular Dynamics Study of the Inhibition of Monomeric HIV‐1 Protease as An Alternative to Overcome Drug Resistance by RNA Aptamers as A Therapeutic Tool
Marzieh Ajamgard (2020)
10.1101/2020.08.09.243030
DEER-PREdict: Software for Efficient Calculation of Spin-Labeling EPR and NMR Data from Conformational Ensembles
G. Tesei (2020)
From bedside to bench and back : future options for antiretroviral drugs in non-B HIV-1 subtypes
D. Njenda (2020)
10.1016/j.jmgm.2020.107826
Understanding the mechanism of HIV-1 protease inhibition by monoclonal antibodies.
Suchetana Gupta (2020)
10.1007/978-3-030-37141-8_10
Detection of HIV-1 Protease Cleavage Sites via Hidden Markov Model and Physicochemical Properties of Amino Acids
Elif Doğan Dar (2020)
10.1016/j.bmc.2020.115623
Design and biological evaluation of novel HIV-1 protease inhibitors with isopropanol as P1' ligand to enhance binding with S1' subsite.
Mei Zhu (2020)
10.1021/acs.jpcb.0c02009
How Good is Jarzynski’s Equality for Computer-Aided Drug Design?
Kiet Ho (2020)
10.1039/c9cp05639d
Concerted hydrolysis mechanism of HIV-1 natural substrate against subtypes B and C-SA PR: insight through molecular dynamics and hybrid QM/MM studies.
Z. Sanusi (2020)
10.1080/07391102.2020.1832578
Exploring the concerted mechanistic pathway for HIV-1 PR-substrate revealed by umbrella sampling simulation.
Z. Sanusi (2020)
10.1021/acsabm.0c00899
Turn-On Assay for HIV-1 Protease Inhibitor Selection
Yan Shi (2020)
10.1002/9781118681121.ch22
Integrating Evolution of Drug Resistance into Drug Discovery
Ayşegül Özen (2020)
10.1002/pro.4013
A synergy of activity, stability, and inhibitor‐interaction of HIV‐1 protease mutants evolved under drug‐pressure
Shahid N. Khan (2020)
10.1021/acs.jmedchem.0c00202
Structure-Based Design of Highly Potent HIV-1 Protease Inhibitors Containing New Tricyclic Ring P2-Ligands: Design, Synthesis, Biological, and X-ray Structural Studies.
Arun K. Ghosh (2020)
10.1016/j.virusres.2020.198258
Conditional activation of an HIV-1 protease attenuated mutant by a leucine zipper dimerization motif.
Fu-Hsien Yu (2020)
10.3390/molecules25092070
Structure-Activity-Relationship and Mechanistic Insights for Anti-HIV Natural Products
R. Kaur (2020)
10.1021/acs.jctc.8b01239
Heterogeneous CPU+GPU-Enabled Simulations for DFTB Molecular Dynamics of Large Chemical and Biological Systems.
Sarah I Allec (2019)
10.1107/S2053273319000482
Extension of the transferable aspherical pseudoatom data bank for the comparison of molecular electrostatic potentials in structure-activity studies.
Prashant Kumar (2019)
10.1016/J.JTICE.2019.07.019
Interactions between HIV-1 protease, silver nanoparticles, and specific peptides
Chieh-Hsuan Tsai (2019)
See more
Semantic Scholar Logo Some data provided by SemanticScholar